| RS1057521085 |
ALPL
|
Health Risk |
Pathogenic/Likely pathogenic |
Osteogenesis imperfecta, Adult hypophosphatasia |
| RS1057521087 |
FUCA1
|
Health Risk |
Likely pathogenic |
— |
| RS1057521090 |
NPHP3
|
Health Risk |
Conflicting classifications of pathogenicity |
Nephronophthisis, Fibrotic kidney disease |
| RS1057521091 |
STAT3
|
Health Risk |
Pathogenic |
Hyper-IgE recurrent infection syndrome 1, autosomal dominant |
| RS1057521092 |
GCK
|
Health Risk |
Pathogenic |
Monogenic diabetes, Maturity-onset diabetes of the young type 2 |
| RS1057521093 |
GCK
|
Health Risk |
Pathogenic |
Monogenic diabetes, Monogenic diabetes |
| RS1057521094 |
GCK
|
Health Risk |
Pathogenic |
Maturity-onset diabetes of the young, GCK-related disorder |
| RS1057521095 |
VDR
|
Health Risk |
Likely pathogenic |
Vitamin D-dependent rickets type II with alopecia, Vitamin D-dependent rickets type II with alopecia |
| RS1057521096 |
MITF
|
Health Risk |
Pathogenic/Likely pathogenic |
Waardenburg syndrome type 2A, Melanoma |
| RS1057521097 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1057521098 |
NF1
|
Health Risk |
Likely pathogenic |
Neurofibromatosis, type 1 |
| RS1057521100 |
FBN1
|
Health Risk |
Likely pathogenic |
Marfan syndrome, Familial thoracic aortic aneurysm and aortic dissection |
| RS1057521101 |
FBN1
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial thoracic aortic aneurysm and aortic dissection, Marfan syndrome |
| RS1057521102 |
FBN1
|
Health Risk |
Pathogenic |
Marfan syndrome, Familial thoracic aortic aneurysm and aortic dissection |
| RS1057521103 |
FBN1
|
Health Risk |
Likely pathogenic |
Marfan syndrome, Familial thoracic aortic aneurysm and aortic dissection |
| RS1057521104 |
PLA2G6
|
Health Risk |
Likely pathogenic |
— |
| RS1057521105 |
ACTA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Aortic aneurysm, familial thoracic 6 |
| RS1057521106 |
COL3A1
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, type 4 |
| RS1057521108 |
TCOF1
|
Health Risk |
Pathogenic/Likely pathogenic |
Treacher Collins syndrome 1, Treacher Collins syndrome 1 |
| RS1057521110 |
MEN1
|
Health Risk |
Likely pathogenic |
Multiple endocrine neoplasia, type 1 |
| RS1057521111 |
MEN1
|
Health Risk |
Pathogenic/Likely pathogenic |
Multiple endocrine neoplasia, type 1 |
| RS1057521112 |
RHO
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS1057521113 |
SMARCA4
|
Health Risk |
Likely pathogenic |
— |
| RS1057521114 |
ACADM
|
Health Risk |
Likely pathogenic |
— |
| RS1057521115 |
ASPA
|
Health Risk |
Pathogenic/Likely pathogenic |
Spongy degeneration of central nervous system, Canavan Disease |
| RS1057521116 |
BTK
|
Health Risk |
Likely pathogenic |
— |
| RS1057521117 |
ACTA1
|
Health Risk |
Pathogenic |
ACTA1 gene related myopathy, Actin accumulation myopathy |
| RS1057521118 |
ACTA1
|
Health Risk |
Pathogenic/Likely pathogenic |
Actin accumulation myopathy, Actin accumulation myopathy |
| RS1057521119 |
ACTA1
|
Health Risk |
Pathogenic/Likely pathogenic |
Actin accumulation myopathy, Actin accumulation myopathy |
| RS1057521120 |
ACTA1
|
Health Risk |
Pathogenic/Likely pathogenic |
Actin accumulation myopathy, Progressive scapulohumeroperoneal distal myopathy |
| RS1057521121 |
AR
|
Health Risk |
Likely pathogenic |
— |
| RS1057521122 |
AR
|
Health Risk |
Conflicting classifications of pathogenicity |
Androgen resistance syndrome, Kennedy disease |
| RS1057521126 |
HMBS
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS1057521127 |
CD40LG
|
Health Risk |
Conflicting classifications of pathogenicity |
Hyper-IgM syndrome type 1, Hyper-IgM syndrome type 1 |
| RS1057521128 |
CD40LG
|
Health Risk |
Likely pathogenic |
Hyper-IgM syndrome type 1, Hyper-IgM syndrome type 1 |
| RS1057521129 |
CASR
|
Health Risk |
Likely pathogenic |
Familial hypocalciuric hypercalcemia, Autosomal dominant hypocalcemia 1 |
| RS1057521130 |
COMP
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS1057521131 |
EDA
|
Health Risk |
Pathogenic/Likely pathogenic |
Hypohidrotic X-linked ectodermal dysplasia, Hypohidrotic X-linked ectodermal dysplasia |
| RS1057521132 |
EXT2
|
Health Risk |
Pathogenic |
Exostoses, multiple |
| RS1057521133 |
IRF6
|
Health Risk |
Likely pathogenic |
— |
| RS1057521135 |
SPAST
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 4, Hereditary spastic paraplegia 4 |
| RS1057521137 |
HEXA
|
Health Risk |
Conflicting classifications of pathogenicity |
Tay-Sachs disease, Tay-Sachs disease |
| RS1057521138 |
IKBKG
|
Health Risk |
Pathogenic |
— |
| RS1057521140 |
KRIT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Cerebral cavernous malformation, KRIT1-related disorder |
| RS1057521141 |
DYSF
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2B, Neuromuscular disease caused by qualitative or quantitative defects of dysferlin |
| RS1057521142 |
NSD1
|
Health Risk |
Likely pathogenic |
— |
| RS1057521143 |
PHEX
|
Health Risk |
Pathogenic |
— |
| RS1057521144 |
PHEX
|
Health Risk |
Pathogenic |
Familial X-linked hypophosphatemic vitamin D refractory rickets, Familial X-linked hypophosphatemic vitamin D refractory rickets |
| RS1057521145 |
SALL4
|
Health Risk |
Pathogenic |
— |
| RS1057521146 |
SGSH
|
Health Risk |
Conflicting classifications of pathogenicity |
Mucopolysaccharidosis, MPS-III-A |
| RS1057521147 |
SLC26A4
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 4, Pendred syndrome |
| RS1057521149 |
SPTAN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Early-infantile DEE |
| RS1057521150 |
TGFB2
|
Health Risk |
Pathogenic/Likely pathogenic |
Loeys-Dietz syndrome 4, Familial thoracic aortic aneurysm and aortic dissection |
| RS1057521151 |
DPAGT1
|
Health Risk |
Pathogenic/Likely pathogenic |
DPAGT1-congenital disorder of glycosylation, Congenital myasthenic syndrome 13 |
| RS1057521152 |
COL6A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS1057521153 |
COLQ
|
Health Risk |
Likely pathogenic |
— |
| RS1057521154 |
CLCNKB
|
Health Risk |
Likely pathogenic |
— |
| RS1057521155 |
SLC40A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Hemochromatosis type 4, Hemochromatosis type 4 |
| RS1057521162 |
FBN2
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital contractural arachnodactyly, Congenital contractural arachnodactyly |
| RS1057521166 |
POLD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Colorectal cancer |
| RS1057521167 |
TP53
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Li-Fraumeni syndrome |
| RS1057521174 |
NEB
|
Health Risk |
Conflicting classifications of pathogenicity |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS1057521175 |
DDX3X
|
Health Risk |
Pathogenic |
— |
| RS1057521176 |
POLR3A
|
Health Risk |
Likely pathogenic |
— |
| RS1057521178 |
HSPG2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1057521184 |
BRCA2
|
Health Risk |
Likely pathogenic |
Hereditary breast ovarian cancer syndrome, Hereditary breast ovarian cancer syndrome |
| RS1057521203 |
ACVRL1
|
Health Risk |
Pathogenic/Likely pathogenic |
Telangiectasia, hereditary hemorrhagic |
| RS1057521205 |
RYR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Catecholaminergic polymorphic ventricular tachycardia 1, Arrhythmogenic right ventricular dysplasia 2 |
| RS1057521207 |
FBN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial thoracic aortic aneurysm and aortic dissection, Marfan syndrome |
| RS1057521211 |
FBN1
|
Health Risk |
Likely pathogenic |
— |
| RS1057521223 |
SCN2A
|
Health Risk |
Likely pathogenic |
— |
| RS1057521224 |
KANSL1
|
Health Risk |
Conflicting classifications of pathogenicity |
Koolen-de Vries syndrome, Koolen-de Vries syndrome |
| RS1057521233 |
MLH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary nonpolyposis colorectal neoplasms |
| RS1057521238 |
AKAP9
|
Health Risk |
Conflicting classifications of pathogenicity |
Long QT syndrome, Cardiovascular phenotype |
| RS1057521243 |
PAFAH1B1
|
Health Risk |
Likely pathogenic |
— |
| RS1057521250 |
TUBB2A
|
Health Risk |
Conflicting classifications of pathogenicity |
See cases, Complex cortical dysplasia with other brain malformations 5 |
| RS1057521251 |
CCNQ
|
Health Risk |
Likely pathogenic |
— |
| RS1057521256 |
PCDH19
|
Health Risk |
Pathogenic/Likely pathogenic |
Developmental and epileptic encephalopathy, 9 |
| RS1057521267 |
STK11
|
Health Risk |
Conflicting classifications of pathogenicity |
Peutz-Jeghers syndrome, Hereditary cancer-predisposing syndrome |
| RS1057521291 |
POLD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1057521317 |
CSTB
|
Health Risk |
Conflicting classifications of pathogenicity |
Progressive myoclonic epilepsy, Unverricht-Lundborg syndrome |
| RS1057521321 |
DMD
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1057521325 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary breast ovarian cancer syndrome |
| RS1057521355 |
STK11
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Peutz-Jeghers syndrome |
| RS1057521358 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1057521374 |
POLD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Colorectal cancer, susceptibility to |
| RS1057521378 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Hereditary cancer-predisposing syndrome |
| RS1057521396 |
TNNC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1Z, Hypertrophic cardiomyopathy 13 |
| RS1057521423 |
SYNE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Emery-Dreifuss muscular dystrophy 4, autosomal dominant |
| RS1057521425 |
FH
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary leiomyomatosis and renal cell cancer |
| RS1057521452 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Ataxia-telangiectasia syndrome |
| RS1057521475 |
CHM
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS1057521489 |
PLCB4
|
Health Risk |
Likely pathogenic |
— |
| RS1057521506 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS1057521516 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Colorectal cancer, susceptibility to |
| RS1057521530 |
TNNI3
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypertrophic cardiomyopathy, Hypertrophic cardiomyopathy |
| RS1057521537 |
SCN1A
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, Developmental and epileptic encephalopathy |
| RS1057521551 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1057521554 |
RBM20
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1DD, Cardiomyopathy |
| RS1057521558 |
CREBBP
|
Health Risk |
Conflicting classifications of pathogenicity |
— |